Challenges of Screening and Investigations of Contacts of Patients with Tuberculosis in Oyo and Osun States, Nigeria
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Study Area
2.3. Target Population
2.4. Sample Size
2.5. Sampling Techniques
2.6. Instruments and Data Collection
2.7. Data Management and Analysis
3. Results
3.1. Respondents/Participants Sociodemographic Characteristics
3.2. Challenges with TB Screening
“One of our key challenges is a grossly inadequate number of screening tools. I mean the gene expert that is meant for the test. Presently, we have 13 gene experts and other testing facilities, but it is not enough; it is grossly inadequate. As it is what we are having in this is that we do not get results within 24 h. The result often takes three, four, or six weeks, and you can imagine that when people get to laboratories and are not getting their results, you can imagine what will happen. So they will go back to the community. So, when people are not treated, the infection continues circulating in the community.”
“We are also not having adequate reporting and recording tools…these things are grossly inadequate…we do not have adequate HIV testing kits, and it is affecting us; we need to test every identified tuberculosis, whether they have a TB as well as HIV is very important…the other thing is HR, we have a very minimal number of human resources, we do not have enough DOT staffs in our facilities…we also need a project vehicle to be able to have supervision…so, we need a vehicle to move around from time to time every quarter to see that our patients are given all the standard drugs. So, these are the few critical challenges we have; if we have a solution, it goes a long way to improve the States.”
“In terms of tracing patients, we have challenges. Before, they used to give us a motorcycle that we use to trace the patients in the community; they gave us everything we needed to maintain it, but now, we do not have such a thing, and they do not supply us with a motorcycle again...”
“Those that have TB are usually stubborn and completely disagree that they do not have TB; some will agree to start drugs that same day, and you know that drug works like magic when they start using drugs for two weeks, and they have been relieved, they tell us they are no longer using drugs, some will run away, we look for them, we will call them, some of them will start abusing us on the phone. They once told us they would beat us if we passed their area. It happened before when I started working, and that is one of our challenges.”
“When you get to the field, you will only see females showing up for TB screening. Now, let us put it that it is in the natural nature of men to hustle…they are out there, and they do not have time for this. Now, they can be the major carrier, or they can also be the ones to catch it some other time out there in the field; females tend to turn out more than males, so what can happen there is that whichever way the awareness should be done or sensitisation about male coming out whenever there is an outreach, I would encourage that.”
3.3. Investigation of Contacts of Patients with TB
“The issue of the availability of drugs, we do not have enough 3HR, i.e., three months drugs that supposed to be were distributed. So, we are now prioritising what you have in store as being distributed with our normal drug out or commodity in the market based on the high burden. Whereas every facility that handles patients is supposed to have enough drugs so that any contact is identified. We also do not have enough recording and reporting tools for this contact investigation, so certain forms must be used for contact tracing.”
3.4. Strategies Currently Employed in Filling the Gaps
3.5. Proposed Strategies for Overcoming the Perceived Challenges
“You know counselling is an ongoing process, a continual process. So, maybe TB-LON 3 can assist in training some of our health workers on counselling, on how to counsel a patient, awareness counselling on pre and post-test counselling, and that area of counselling so that we inculcate it in them so that they would be a good counsellor That one will help us.”
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A
Osun State | ||||
---|---|---|---|---|
S/N | LGA | FACILITY | FGD (TBP, HTBC, CV) | KII (DOTS Officers, TBLS, STBLM, WDC Chair) |
1 | Iwo | Feesu PHC | 3 | 3 |
2 | Ede South | State Hospital Ede | 3 | 3 |
3 | Ife Central | Enuwa PHC | 3 | 3 |
4 | Osogbo | State Hospital, Asubiaro | 3 | 3 |
TB-LON 3 project staff | 2 | |||
Subtotal | 12 | 14 + 1 (STBLPM) | ||
Oyo State | ||||
1 | Ibadan North | PHC Sabo | 3 | 3 |
2 | Oyo East | State Hospital, Oyo | 3 | 3 |
3 | Ogbomoso South | PHC Igboyi | 3 | 3 |
4 | Iseyin | General Hospital Iseyin | 3 | 3 |
TB-LON 3 project staff | 2 | |||
Subtotal | 12 | 14 + 1 (STBLPM) | ||
Grand Total | 24 FGDs | 30 KIIs |
Sociodemographic Variables | KII (N = 30) | FGD (N = 120) |
---|---|---|
Age * | ||
15–34 | 2 (4.1%) | 47 (95.9%) |
35–60 | 26 (31.7%) | 56 (68.3%) |
61 and above | 2 (10.5%) | 17 (89.5%) |
Sex | ||
Male | 21 (24.4%) | 65 (75.6%) |
Female | 9 (14.1%) | 55 (85.9%) |
Marital status | ||
Single | 7 (16.3) | 36 (83.7) |
Married | 22 (22.4%) | 76 (77.6%) |
Separated | 0 (0.0%) | 3 (100.0%) |
Divorced | 0 (0.0%) | 3 (100.0%) |
Widow/widower | 1 (25.0%) | 3 (75.0%) |
Religion | ||
Islam | 15 (17.6%) | 70 (82.4%) |
Christianity | 14 (22.6%) | 48 (77.4%) |
Traditional | 1 (33.3%) | 2 (66.7%) |
Ethnicity | ||
Yoruba | 29 (20.0%) | 116 (80.0%) |
Igbo | 1 (33.3%) | 2 (66.7%) |
Others | 0 (0.0%) | 2 (100.0%) |
Level of education | ||
None | 0 (0.0%) | 12 (100.0%) |
Primary | 6 (17.6%) | 28 (82.4%) |
Secondary | 5 (8.5%) | 54 (91.5%) |
OND/NCE | 4 (30.8%) | 9 (69.2%) |
HND/First Degree | 12 (46.2%) | 14 (53.8%) |
Postgraduate degree | 3 (50.0%) | 3 (50.0%) |
Occupation | ||
Civil or public servant | 18 (62.1%) | 11 (37.9%) |
Trader | 3 (8.1%) | 34 (91.9%) |
Farmer or fisherman | 1 (12.5%) | 7 (87.5%) |
Artisan | 0 (0.0%) | 26 (100.0%) |
Unemployed | 0 (0.0%) | 12 (100.0%) |
Others | 8 (21.1%) | 30 (78.9%) |
Respondent classification | ||
TB patients | 0 (0.0%) | 47 (100.0%) |
Government Staff | 18 (100.0%) | 0 (0.0%) |
TB contacts | 0 (0.0%) | 39 (100.0%) |
WDC Chair | 9 (100.0%) | 0 (0.0%) |
Community Volunteer | 0 (0.0%) | 34 (100.0%) |
IHVN Staff | 3 (100.0%) | 0 (0.0%) |
Challenges | Strategies |
---|---|
|
|
References
- World Health Organization (WHO). Global Tuberculosis Report 2023; World Health Organization: Geneva, Switzerland, 2023. [Google Scholar]
- KNCV Nigeria. TB in Nigeria: A Major Issue with TB in Nigeria Is the Low TB Case Finding for Both Adults and Children. 2023. Available online: https://kncvnigeria.org/nigeria-is-among-the-14-high-burden-countries-for-tb/ (accessed on 14 March 2024).
- Yuen, C.M.; Amanullah, F.; Dharmadhikari, A.; Nardell, E.A.; Seddon, J.A.; Vasilyeva, I.; Zhao, Y.; Keshavjee, S.; Becerra, M.C. Turning off the Tap: Stopping Tuberculosis Transmission through Active Case-Finding and Prompt Effective Treatment. Lancet 2015, 386, 2334–2343. [Google Scholar] [CrossRef] [PubMed]
- Federal Ministry of Health. National TB and Leprosy Control Program Annual Report 2019. 2019. Available online: https://www.health.gov.ng/doc/Draft-2019-NTBLCP-Annual-report-22032020.pdf (accessed on 23 May 2024).
- Onuka, O.; Okezie, I.; Ahukanna, J.; Okebaram, C.; Dakum, P.; Agbaje, A.; Ibeziako, V.; Mustapha, G.; Chukwueme, N.; Ubochioma, E.; et al. Effectiveness of Contact Tracing of Index Tuberculosis Cases in Nigeria. Adv. Infect. Dis. 2018, 8, 173–199. [Google Scholar] [CrossRef]
- Azuogu, B.N.; Ogbonnaya, L.U.; Obumneme-Anyim, N. Contact tracing as a strategy for tuberculosis control in Nigeria: A review. Int. J. Mycobacteriology 2019, 8, 1–7. [Google Scholar]
- Oshi, D.C.; Oshi, S.N.; Alobu, I.; Ukwaja, K.N. Profile and determinants of treatment failure among smear-positive tuberculosis patients in Ebonyi, Nigeria. Afr. Health Sci. 2017, 17, 698–706. [Google Scholar]
- Adejumo, O.A.; Daniel, O.J.; Otesanya, A.F. Community involvement in tuberculosis control in Lagos, Nigeria: Why does it work in some areas and not in others? Trans. R. Soc. Trop. Med. Hyg. 2016, 110, 75–81. [Google Scholar]
- Lawson, L.; Muc, M.; Oladimeji, O.; Iweha, C.; Opoola, B.; Abdurhaman, S.; Bimba, J.S.; Cuevas, L.E. Tuberculosis and diabetes in Nigerian patients with and without HIV. Int. J. Infect. Dis. 2017, 61, 121–125. [Google Scholar] [CrossRef]
- Shamanewadi, A.N.; Naik, P.R.; Thekkur, P.; Madhukumar, S.; Nirgude, A.S.; Pavithra, M.B.; Poojar, B.; Sharma, V.; Urs, A.P.; Nisarga, B.V.; et al. Enablers and Challenges in the Implementation of Active Case Findings in a Selected District of Karnataka, South India: A Qualitative Study. Tuberc. Res. Treat. 2020, 2020, 9746329. [Google Scholar] [CrossRef]
- Aiyegoro, O.A. Determinants of Adherence to Tuberculosis Therapy among Patients Receiving Directly Observed Treatment from a District Hospital in Pretoria, South Africa; University of the Western Cape: Cape Town, South Africa, 2016. [Google Scholar]
- Humayun, M.; Chirenda, J.; Ye, W.; Mukeredzi, I.; Mujuru, H.A.; Yang, Z. Effect of Gender on Clinical Presentation of Tuberculosis (TB) and Age-Specific Risk of TB, and TB-Human Immunodeficiency Virus Coinfection. Open Forum Infect. Dis. 2022, 9, ofac512. [Google Scholar] [CrossRef] [PubMed]
- Horton, K.C.; MacPherson, P.; Houben, R.M.G.J.; White, R.G.; Corbett, E.L. Sex differences in tuberculosis burden and notifications in low- and middle-income countries: A systematic review and meta-analysis. PLoS Med. 2016, 13, e1002119. [Google Scholar] [CrossRef]
- Nhamoyebonde, S.; Leslie, A. Biological differences between the sexes and susceptibility to tuberculosis. J. Infect. Dis. 2014, 209, S100–S106. [Google Scholar] [CrossRef]
- Khatri, G.R.; Frieden, T.R. The status and prospects of tuberculosis control in India. Int. J. Tuberc. Lung Dis. 2000, 4, 193–200. [Google Scholar]
- Chakraborty, A.K. Epidemiology of Tuberculosis: Current Status in India. Indian J. Med. Res. 2004, 120, 248–276. [Google Scholar] [PubMed]
- Chan-Yeung, M.; Tam, C.M.; Wong, H.; Leung, C.C.; Wang, J.; Yew, W.W.; Lam, C.W.; Kam, K.M. Molecular and conventional epidemiology of tuberculosis in Hong Kong: A population-based prospective study. J. Clin. Microbiol. 2003, 41, 2706–2708. [Google Scholar] [CrossRef] [PubMed]
- Bam, D.S.; Gunneberg, C.; Jha, K.K.; Malla, P.; Pant, R.P.; Bam, T.S. Success story of tuberculosis control in Nepal. SAARC J. Tuberc. Lung Dis. HIV AIDS 2006, 1, 43–48. [Google Scholar]
- O’Boyle, S.J.; Power, J.J.; Ibrahim, M.Y.; Watson, J.P. Factors affecting patient compliance with anti-tuberculosis chemotherapy using the directly observed treatment, short course strategy (DOTS). Int. J. Tuberc. Lung Dis. 2002, 6, 307–312. [Google Scholar]
- Pushpananthan, S.; Walley, J.A.; Wright, J. Tuberculosis in Swaziland: A health needs assessment in preparation for a community-based programme. Trop. Dr. 2000, 30, 216–220. [Google Scholar] [CrossRef]
- Gebremariam, M.K.; Bjune, G.A.; Frich, J.C. Lay beliefs of TB and TB/HIV coinfection in Addis Ababa, Ethiopia: A qualitative study. BioMed Cent. Res. Notes 2011, 4, 277. [Google Scholar] [CrossRef]
- Maswanganyi, N.V.; Lebese, R.T.; Mashau, N.S.; Khoza, L.B. Patient-perceived factors contributing to low tuberculosis cure rate at Greater Giyani healthcare facilities. Health SA Gesondheid 2014, 19, 8. [Google Scholar] [CrossRef]
- Iweama, C.N.; Agbaje, O.S.; Umoke, P.C.I.; Igbokwe, C.C.; Ozoemena, E.L.; Omaka-Amari, N.L.; Idache, B.M. Nonadherence to tuberculosis treatment and associated factors among patients using directly observed treatment short-course in north-west Nigeria: A cross-sectional study. SAGE Open Med. 2021, 9, 2050312121989497. [Google Scholar] [CrossRef]
- Ahmed, A.A.; Grammatico, M.; Anthony, P.; Moll, A.P.; Malinga, S.; Makhunga, P.; Charalambous, S.; Ladines-Lim, J.B.; Shenoi, S.V. Factors associated with low tuberculosis preventive therapy prescription rates among health care workers in rural South Africa. Glob. Health Action 2021, 14, 1979281. [Google Scholar] [CrossRef]
- Teklay, G.; Teklu, T.; Legesse, B.; Tedla, K.; Klinkenberg, E. Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: A mixed quantitative and qualitative study. BMC Public Health 2016, 16, 840. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Yunusa, F.; Bello, M.; Kayode, G.A.; Adegboye, A.; Abone, G.; Murtala-Ibrahim, F.; Okposo, M.; Anjorin, A.; Dutt, S.; Yusuf, O.; et al. Uptake of tuberculosis prevention therapy in people living with HIV/AIDS in northern Nigeria: A programme to increase use of isoniazid preventive therapy. Lancet Glob. Health 2020, 8, S37. [Google Scholar] [CrossRef]
- Reddy, M.M.; Thekkur, P.; Ramya, N.; Kamath, P.B.T.; Shastri, S.G.; Kumar, R.B.N.; Chinnakali, P.; Nirgude, A.S.; Rangaraju, C.; Somashekar, N.; et al. To start or to complete?—Challenges in implementing tuberculosis preventive therapy among people living with HIV: A mixed-methods study from Karnataka, India. Glob. Health Action 2020, 13, 1704540. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- World Health Organization. Global Tuberculosis Report 2017: Leave No One Behind—Unite to End TB. 2017. Available online: http://www.who.int/tb/publications/global_report/gtbr2017_main_text.pdf?ua=1 (accessed on 22 March 2024).
- World Health Organization. Global Tuberculosis Report 2020. World Health Organization: Geneva, Switzerland, 2020. Licence: CC BY-NC-SA 3.0 IGO. Available online: https://www.who.int/publications/i/item/9789240013131 (accessed on 22 March 2024).
- Federal Ministry of Health. Standard Operating Procedure for Contact Investigation and Tuberculosis Preventive Treatment. National Tuberculosis, Leprosy and Buruli Ulcer Control Programme. 2022. Available online: https://ntblcp.org.ng/content/uploads/2023/06/FINAL-SOP-CONTACT-INVESTIGATION-AND-TPT_JAN-2021-1.pdf (accessed on 24 March 2024).
- Morrison, J.; Pai, M.; Hopewell, P.C. Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: A systematic review and meta-analysis. Lancet Infect. Dis. 2008, 8, 359–368. [Google Scholar] [CrossRef]
- World Health Organization. Recommendations for Investigating Contacts of Persons with Infectious Tuberculosis in Low and Middle-Income Countries. 2012. Available online: http://www.who.int/tb/publications/2012/contact_investigation2012/en/ (accessed on 22 March 2024).
- Macq, J.; Solis, A.; Martinez, G. Assessing the stigma of tuberculosis. Psychol. Health Med. 2006, 11, 346–352. [Google Scholar] [CrossRef] [PubMed]
- Xu, W.; Lu, W.; Zhou, Y.; Zhu, L.; Shen, H.; Wang, J. Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: A qualitative and quantitative study. BMC Health Serv. Res. 2009, 9, 169. [Google Scholar] [CrossRef]
- Sulis, G.; Roggi, A.; Matteelli, A.; Raviglione, M.C. Tuberculosis: Epidemiology and control. Mediterr. J. Hematol. Infect. Dis. 2014, 6, e2014070. [Google Scholar] [CrossRef]
- The Union. Tackling TB Stigma—A Necessary Step Towards Humanising TB, Viewed. 25 July 2017. Available online: https://www.theunion.org/news-centre/news/tackling-tb-stigma-humanising-tb (accessed on 18 March 2024).
- Christodoulou, M. The stigma of tuberculosis. Lancet Infect. Dis. 2011, 11, 663–664. [Google Scholar] [CrossRef] [PubMed]
- Baral, S.C.; Karki, D.K.; Newell, J.N. Causes of stigma and discrimination associated with tuberculosis in Nepal: A qualitative study. BMC Public Health 2007, 7, 211. [Google Scholar] [CrossRef]
- Cremers, A.L.; de Laat, M.M.; Kapata, N.; Gerrets, R.; Klipstein-Grobusch, K.; Grobusch, M.P. Assessing the Consequences of Stigma for Tuberculosis Patients in Urban Zambia. PLoS ONE 2015, 10, e0119861. [Google Scholar] [CrossRef]
- TB Alert. Stigma and Myths. 24 October 2018. Available online: https://www.tbalert.org/about-tb/global-tb-challenges/stigma-myths/ (accessed on 18 March 2024).
- Ngamvithayapong, J.; Winkvist, A.; Diwan, V. High AIDS awareness may cause tuberculosis patient delay: Results from an HIV epidemic area, Thailand. AIDS 2000, 14, 1413–1419. [Google Scholar] [CrossRef] [PubMed]
- Coreil, J.; Mayard, G.; Simpson, K.M.; Lauzardo, M.; Zhu, Y.; Weiss, M. Structural forces and the production of TB-related stigma among Haitians in two contexts. Soc. Sci. Med. 2010, 71, 1409–1417. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Agbaje, A.; Dakum, P.; Daniel, O.; Chukwuma, A.; Chijoke-Akaniro, O.; Okpokoro, E.; Akingbesote, S.; Anyomi, C.; Adekunle, A.; Alege, A.; et al. Challenges of Screening and Investigations of Contacts of Patients with Tuberculosis in Oyo and Osun States, Nigeria. Trop. Med. Infect. Dis. 2024, 9, 144. https://doi.org/10.3390/tropicalmed9070144
Agbaje A, Dakum P, Daniel O, Chukwuma A, Chijoke-Akaniro O, Okpokoro E, Akingbesote S, Anyomi C, Adekunle A, Alege A, et al. Challenges of Screening and Investigations of Contacts of Patients with Tuberculosis in Oyo and Osun States, Nigeria. Tropical Medicine and Infectious Disease. 2024; 9(7):144. https://doi.org/10.3390/tropicalmed9070144
Chicago/Turabian StyleAgbaje, Aderonke, Patrick Dakum, Olugbenga Daniel, Anyaike Chukwuma, Obioma Chijoke-Akaniro, Evaezi Okpokoro, Samuel Akingbesote, Christian Anyomi, Adekola Adekunle, Abiola Alege, and et al. 2024. "Challenges of Screening and Investigations of Contacts of Patients with Tuberculosis in Oyo and Osun States, Nigeria" Tropical Medicine and Infectious Disease 9, no. 7: 144. https://doi.org/10.3390/tropicalmed9070144
APA StyleAgbaje, A., Dakum, P., Daniel, O., Chukwuma, A., Chijoke-Akaniro, O., Okpokoro, E., Akingbesote, S., Anyomi, C., Adekunle, A., Alege, A., Gbadamosi, M., Babalola, O., Mensah, C., Eneogu, R., Ihesie, A., & Adelekan, A. (2024). Challenges of Screening and Investigations of Contacts of Patients with Tuberculosis in Oyo and Osun States, Nigeria. Tropical Medicine and Infectious Disease, 9(7), 144. https://doi.org/10.3390/tropicalmed9070144